Stage IIB Cutaneous Melanoma AJCC v6 and v7
2 clinical trials · Condition
◉ Watch Stage IIB Cutaneous Melanoma AJCC v6 and v7
| Record | Firm | Date |
|---|---|---|
| A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma (NCT02129075) | National Cancer Institute (NCI) | 2014-04-09 |
| Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery (NCT01989572) | National Cancer Institute (NCI) | 2000-02-23 |
Track Stage IIB Cutaneous Melanoma AJCC v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.